Correlation Between Platelet Aggregation and Dephosphorylation of a 68 kDa Protein Revealed through the Use of Putative PKC Inhibitors

Summary

The efficacy of two structurally and functionally unrelated protein kinase C (PKC) inhibitors, chelerythrine and calphostin C, was assessed in intact human platelets by studying platelet aggregation in response to Stimulation with phorbol 12-myristate 13-acetate (PMA) or the thromboxane-A₂ mimetic, U46619. Surprisingly, both inhibitors increased aggregation in response to PMA, but decreased aggregation in response to U46619. To further explore this phenomenon, gel electrophoresis of ³²P-labelled proteins from PMA- or U46619-stimulated platelets in the presence and absence of the two putative PKC inhibitors was performed. Although neither chelerythrine nor calphostin C proved to be effective PKC inhibitors in intact human platelets, a strong correlation between the dephosphorylation of a 68 kDa protein and the rate of platelet aggregation was observed. From these results, the indiscriminate use of PKC inhibitors in whole platelets is questioned and attention is drawn to the role of protein dephosphorylation in platelet activation. The 68 kDa protein was the major phosphorylated substrate in resting platelets. Okadaic acid increased phosphorylation of this band, indicating active phosphate group turnover under resting conditions.

• References

• 1 Nishizuka Y. The role of protein kinase C in cell surface signal transduction and tumor promotion. Nature 1984; 308: 693-698
• 2 Takai Y, Kishimoto A, Inoue M, Nishizuka Y. Studies on the cyclic nucleotide-independent protein kinase and its proenzyme in mammalian tissues I. Purification and characterization of an active enzyme from bovine cerebellum. J Biol Chem 1977; 252: 7603-7609
• 3 Inoue M, Kishimoto A, Nishizuka Y. Studies on the cyclic nucleotide-independent protein kinase and its proenzyme in mammalian tissues. II. Proenzyme and its activation by calcium-dependent protease from rat brain. J Biol Chem 1977; 252: 7610-7616
• 4 Stabei S, Parker PJ. Protein kinase-C. Pharmacol Ther 1991; 51: 71-95
• 5 Blumberg PM. Complexities of the protein kinase-C pathway. Mol Carcinogenesis 1991; 4: 339-344
• 6 Crabos M, Imber R, Woodtli T, Fabbro D, Erne P. Different translocation of three distinct PKC isoforms with tumor-promoting phorbol ester in human platelets. Biochem Biophys Res Commun 1991; 178: 878-883
• 7 Tsukuda M, Asaoka Y, Sekiguchi K, Kikkawa U, Nishizuka Yasutomi. Properties of protein kinase C subspecies in human platelets. Biochem Biophys Res Commun 1988; 155: 1387-1395
• 8 Ono Y, Fujii T, Ogita K, Kikkawa U, Igarashi K, Nishizuka Y. Protein kinase C zeta subspecies from rat brain: Its structure, expression, and properties. Proc Natl Acad Sci USA 1989; 86: 3099-3103
• 9 Davis PD, Hill CH, Keech E, Lawton G, Nixon JS, Sedgwick AD, Wadsworth J, Westmacott D, Wilkinson SE. Potent selective inhibitors of protein kinase C. FEBS Lett 1989; 259: 61-63
• 10 Junco M, Diazguerra MJM, Bosca L. Substrate-dependent inhibition of protein kinase-C by specific inhibitors. FEBS Lett 1990; 263: 169-171
• 11 Tamaoki T, Nakano H. Potent and specific inhibitors of protein kinase-C of microbial origin. Bio/Technology 1990; 8: 732-735
• 12 Twomey B, Muid RE, Nixon JS, Sedgwick AD, Wilkinson SE, Dale MM. The effect of new potent selective inhibitors of protein kinase-C on the neutrophil respiratory burst. Biochem Biophys Res Commun 1990; 171: 1087-1092
• 13 Mustard JF, Perry DW, Ardlie NG, Packam MA. Preparations of suspensions of washed platelets from human. Br J Haematol 1972; 22: 193-204
• 14 Bruns RF, Miller FD, Merriman RL, Howbert JJ, Heath WF, Kobayashi E, Takahashi I, Tamaoki T, Nakano H. Inhibition of protein kinase C by calphostin C is light-dependent. Biochem Biophys Res Commun 1991; 176: 288-293
• 15 Born GVR. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 1962; 194: 927-929
• 16 Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacterophage T4. Nature 1970; 227: 680-685
• 17 Siess W. Molecular mechanisms of platelet activation. Physiol Rev 1989; 69: 58-178
• 18 Castagna M, Takai Y, Kaibuchi K, Sano K, Kikkawa U, Nishizuka Y. Direct activation of calcium-activated phospholipid-dependent protein kinase by tumor-promoting phorbol esters. J Biol Chem 1982; 257: 7847-7851
• 19 Sharkey NA, Leach KL, Blumberg PM. Competitive inhibition by diacylglycerol of specific phorbol ester binding. Proc Natl Acad Sci USA 1984; 81: 607-610
• 20 Herbert JM, Augereau JM, Gleye J, Maffrano JP. Chelerythrine is a potent and specific inhibitor of protein kinase C. Biochem Biophys Res Commun 1990; 172: 993-999
• 21 Kobayashi E, Nakano H, Morimoto M, Tamaoki T, Calphostin C. (UCN-1028C) a novel is a highly potent and specific inhibitor of protein kinase C. Biochem Biophys Res Commun 1989; 159: 548-553
• 22 Hagiwara M, Sumi M, Usuda N, Nagata T, Hidaka H. Discrepancy of protein kinase-C translocation and platelet aggregation immunocy-tobiochemical evidence. Arch Biochem Biophys 1990; 280: 201-205
• 23 Haslam R J, Lynham JA. Relationship between phosphorylation of blood platelet proteins and secretion of platelet granule constituents. I. Effects of different aggregating agents. Biochem Biophys Res Commun 1977; 77: 714-715
• 24 Ways DK, Cook PP, Webster C, Parker PJ. Effect of phorbol esters on protein kinase C-ζ. J Biol Chem 1982; 267: 4799-4805
• 25 Ferrell JE, Martin GS. Thrombin stimulates the activities of multiple previously unidentified protein kinases in platelets. J Biol Chem 1989; 264: 20723-20729
• 26 Wallace WC, Bensusan HB. Protein phosphorylation in platelets stimulated by immobilized thrombin at 37°C and 4°C. J Biol Chem 1980; 255: 1932-1937
• 27 Lerea KM. Thrombin-induced effects are selectively inhibited following treatment of intact human platelets with okadaic acid. Biochemistry 1991; 30: 6819-6824
• 28 Chiang TM. Okadaic acid and vanadate inhibit collagen-induced platelet aggregation: The functional relation of phosphatases on platelet aggregation. Thromb Res 1992; 67: 345-354